| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |